AI-assisted, human-published
12/10/2024 /Funding Events
Orthogon Therapeutics Exceeds Funding Target to Accelerate Antiviral Medicine Development
Orthogon Therapeutics secures over $5.2 million to accelerate the development of novel antiviral medicines for managing BK virus reactivation in transplant patients, leveraging advanced drug design and biophysics.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com